Evaluation of different POCT devices for glucose measurement in a clinical neonatal setting.

Hypoglycaemia is a major cause of neonatal morbidity and may induce long-term developmental sequelae. Clinical signs of hypoglycaemia in neonatal infants are unspecific or even absent, and therefore, precise and accurate methods for the assessment of glycaemia are needed. Glycaemia measurement in newborns has some particularities like a very low limit of normal glucose concentration compared to adults and a large range of normal haematocrit values. Many bedside point-of-care testing (POCT) systems are available, but literature about their accuracy in newborn infants is scarce and not very convincing. In this retrospective study, we identified over a 1-year study period 1,324 paired glycaemia results, one obtained at bedside with one of three different POCT systems (Elite? XL, Ascensia? Contour? and ABL 735) and the other in the central laboratory of the hospital with the hexokinase reference method. All three POCT systems tended to overestimate glycaemia values, and none of them fulfilled the ISO 15197 accuracy criteria. The Elite XL appeared to be more appropriate than Contour to detect hypoglycaemia, however with a low specificity. Contour additionally showed an important inaccuracy with increasing haematocrit. The bench analyzer ABL 735 was the most accurate of the three tested POCT systems. Both of the tested handheld glucometers have important drawbacks in their use as screening tools for hypoglycaemia in newborn infants. ABL 735 could be a valuable alternative, but the blood volume needed is more than 15 times higher than for handheld glucometers. Before daily use in the newborn population, careful clinical evaluation of each new POCT system for glucose measurement is of utmost importance.

Diagnostic des maladies infectieuses: place des "point of care tests" (POCT) [Use of POCT (point of care tests) in the diagnosis of infectious diseases]

Les POCT (point of care tests) ont un grand potentiel d'utilisation en médecine infectieuse ambulatoire grâce à leur rapidité d'exécution, leur impact sur l'administration d'antibiotiques et sur le diagnostic de certaines maladies transmissibles. Certains tests sont utilisés depuis plusieurs années (détection de Streptococcus pyogenes lors d'angine, anticorps anti-VIH, antigène urinaire de S. pneumoniae, antigène de Plasmodium falciparum). De nouvelles indications concernent les infections respiratoires, les diarrhées infantiles (rotavirus, E. coli entérohémorragique) et les infections sexuellement transmissibles. Des POCT, basés sur la détection d'acides nucléiques, viennent d'être introduits (streptocoque du groupe B chez la femme enceinte avant l'accouchement et la détection du portage de staphylocoque doré résistant à la méticilline). POCT have a great potential in ambulatory infectious diseases diagnosis, due to their impact on antibiotic administration and on communicable diseases prevention. Some are in use for long (S. pyogenes antigen, HIV antibodies) or short time (S. pneumoniae antigen, P. falciparum). The additional major indications will be community-acquired lower respiratory tract infections, infectious diarrhoea in children (rotavirus, enterotoxigenic E. coli), and hopefully sexually transmitted infections. Easy to use, these tests based on antigen-antibody reaction allow a rapid diagnosis in less than one hour; the new generation of POCT relying on nucleic acid detection are just introduced in practice (detection of GBS in pregnant women, carriage of MRSA), and will be extended to many pathogens

Fase pré-analítica – o laboratório no papel principal_SPML 2016

O Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) foi criado em 1978 como sendo uma das atribuições do Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA). A sua missão é promover, organizar e coordenar programas de avaliação externa da qualidade (AEQ) para laboratórios que exerçam atividade no setor da saúde. O primeiro programa de AEQ do PNAEQ para avaliação da Fase Pré-Analítica foi distribuído em 2007. Os ensaios são pluridisciplinares, podendo incluir o envio de amostras para avaliação das condições para processamento (aceitação ou rejeição, preparação, acondicionamento), a simulação de requisições médicas, a resposta a questionários, a interpretação de casos-estudo, o levantamento de dados (auditorias ou monitorização de indicadores) ou a realização de chamadas anónimas (“cliente mistério”). O PNAEQ disponibiliza ainda 4 programas em colaboração com a Labquality (Flebotomia e POCT, Química Clínica, Microbiologia e Gases no Sangue) e 1 programa com a ECAT (Hemostase). Em 2015 e 2016, o objetivo dos programas da Fase Pré-Analítica do PNAEQ foi proporcionar o envolvimento do laboratório no processo de avaliação e monitorização da fase pré-analítica, conferindo-lhe ferramentas que lhe permitam realizar a sua autoavaliação. A fase pré-analítica é a que absorve o maior número de erros na análise de amostras biológicas, representando 40% a 70% de todas as falhas ocorridas no processamento analítico (Codagnone et al, 2014). A principal razão está na dificuldade em controlar as variáveis pré-analíticas , uma vez que esta fase envolve inúmeras atividades não automatizadas como a colheita, o manuseamento, o transporte e a preparação das amostras.

Internet Geography: New Spaces of Information

The objective of great investments in telecommunication networks is to approach economies and put an end to the asymmetries. The most isolated regions could be the beneficiaries of this new technological investments wave disseminating trough the territories. The new economic scenarios created by globalisation make high capacity backbones and coherent information society polity, two instruments that could change regions fate and launch them in to an economic development context. Technology could bring international projection to services or products and could be the differentiating element between a national and an international economic strategy. So, the networks and its fluxes are becoming two of the most important variables to the economies. Measuring and representing this new informational accessibility, mapping new communities, finding new patterns and localisation models, could be today’s challenge. In the physical and real space, location is defined by two or three geographical co-ordinates. In the network virtual space or in cyberspace, geography seems incapable to define location, because it doesn’t have a good model. Trying to solve the problem and based on geographical theories and concepts, new fields of study came to light. The Internet Geography, Cybergeography or Geography of Cyberspace are only three examples. In this paper and using Internet Geography and informational cartography, it was possible to observe and analyse the spacialisation of the Internet phenomenon trough the distribution of the IP addresses in the Portuguese territory. This work shows the great potential and applicability of this indicator to Internet dissemination and regional development studies. The Portuguese territory is seen in a completely new form: the IP address distribution of Country Code Top Level Domains (.pt) could show new regional hierarchies. The spatial concentration or dispersion of top level domains seems to be a good instrument to reflect the info-structural dynamic and economic development of a territory, especially at regional level.

Dispositivos médicos para diagnóstico in vitro : impacto operacional, clínico e económico da sua utilização em instituições de saúde

RESUMO - Introdução: Os dispositivos médicos para diagnóstico in vitro (DMDIV) são testes de diagnóstico rápido que podem ser realizados em diversos contextos, seja na enfermaria, no departamento de urgência, no bloco operatório, no consultório médico, centros de enfermagem, farmácias, lares de terceira idade ou até na própria residência, uma vez que a sua utilização não requer formação especializada em técnicas de laboratório. Os DMDIV têm inúmeras finalidades: triagem de utentes, diagnóstico de situações agudas, monitorização de fármacos ou acompanhamento de doenças crónicas. Objectivos: conhecer as potenciais implicações operacionais, clínicas e económicas da implementação generalizada de DMDIV em instituições de saúde da região de Lisboa e Vale do Tejo, bem como conhecer o nível de utilização e opinião sobre DMDIV de médicos e enfermeiros da região de saúde de Lisboa e Vale do Tejo. Metodologia: foi realizado um estudo observacional, analítico e transversal. Como instrumento de recolha de dados, foi aplicado um questionário a uma amostra de conveniência constituída por médicos e enfermeiros a exercer funções em instituições hospitalares públicas e privadas e em instituições de cuidados de saúde primários da região de saúde de Lisboa e Vale do Tejo. Conclusão: a utilização de DMDIV permite diminuir o tempo de resposta do resultado analítico, o que se traduz numa maior rapidez do diagnóstico e numa intervenção clínica mais célere, com impacto ao nível da redução do número de admissões desnecessárias, do tempo de internamento e do número de consultas médicas, com a consequente redução do consumo de recursos hospitalares. Na região de saúde de Lisboa e Vale do Tejo, um número significativo de instituições de saúde disponibiliza este tipo de equipamentos portáteis que, de uma forma geral, têm uma boa aceitação por parte dos profissionais de saúde.

Design e fabrico de novos eléctrodos impressos em papel para desenvolvimento de biossensores enzimáticos com aplicações biomédicas

Num mundo em crescente evolução é necessário tentar melhorar as condições de saúde global. Um factor importante para a prevenção e tratamento de doenças é o seu correcto diagnóstico. Uma vez que nem todos os países têm a mesma capacidade económica, existe a necessidade de se criar testes rápidos e baratos que possam ser acessíveis no mundo inteiro. Os point-of-care tests, como é o caso dos biossensores de glucose vastamente utilizados na monitorização da diabetes, apresentam uma solução para este problema. Os biossensores impressos em papel, em particular, são uma ferramenta que pode vir a ser muito útil na construção destes testes rápidos tornando-os mais “amigos do ambiente” e reduzindo os seus custos. O objectivo deste trabalho foi desenvolver biossensores enzimáticos, de segunda geração, impressos em papel e baseados na enzima glucose oxidase, para a detecção da glucose. Inicialmente foi feito um estudo de possíveis mediadores a utilizar, tendo-se escolhido o ferroceno por apresentar um limite de detecção adequado, ter apresentado um valor de potencial de redução relativamente baixo, 0.232 V vs pseudo ref. Ag/AgCl, ser um composto fácil de obter e com custos reduzidos. Os dispositivos baseiam-se em canais microfluídicos, eléctrodos e ligações eléctricas fabricadas em substrato de papel, utilizando as técnicas de impressão a cera, screen printing e inkjet printing. O circuito constituinte destes dispositivos foi feito recorrendo a tintas condutoras, sendo que, à tinta utilizada para o eléctrodo de trabalho foi incorporado o ferroceno. Sobre o eléctrodo de trabalho foi impressa glucose oxidase, utilizando a técnica de inkjet printing. Os eléctrodos fabricados apresentaram resposta à glucose, muito embora com baixa reprodutibilidade, podendo esta ser causada pela falta de controlo na preparação dos mesmos (manufactura manual e variabilidade da viscosidade da pasta usada no eléctrodo de trabalho). A técnica de inkjet printing em enzimas é ainda muito recente, existindo ainda alguns aspectos, como o seu efeito na actividade da enzima, que não foram avaliados neste projecto, mas que no futuro deverão ser estudados. Podemos concluir que, os eléctrodos deram uma resposta electroquímica consistente à adição de glucose, 8 mM- 30 mM, sendo que os mesmos foram reconhecidos no glucómetro comercial TRUETrackTM blood glucometer; no entanto, os valores de corrente dos dispositivos estavam abaixo do limite de detecção do instrumento.

Towards the validation of "in silico" models and physicochemical filters to identify and characterize new chemical entities

Summary: Lipophilicity plays an important role in the determination and the comprehension of the pharmacokinetic behavior of drugs. It is usually expressed by the partition coefficient (log P) in the n-octanol/water system. The use of an additional solvent system (1,2-dichlorethane/water) is necessary to obtain complementary information, as the log Poct values alone are not sufficient to explain ail biological properties. The aim of this thesis is to develop tools allowing to predict lipophilicity of new drugs and to analyze the information yielded by those log P values. Part I presents the development of theoretical models used to predict lipophilicity. Chapter 2 shows the necessity to extend the existing solvatochromic analyses in order to predict correctly the lipophilicity of new and complex neutral compounds. In Chapter 3, solvatochromic analyses are used to develop a model for the prediction of the lipophilicity of ions. A global model was obtained allowing to estimate the lipophilicity of neutral, anionic and cationic solutes. Part II presents the detailed study of two physicochemical filters. Chapter 4 shows that the Discovery RP Amide C16 stationary phase allows to estimate lipophilicity of the neutral form of basic and acidic solutes, except of lipophilic acidic solutes. Those solutes present additional interactions with this particular stationary phase. In Chapter 5, 4 different IANI stationary phases are investigated. For neutral solutes, linear data are obtained whatever the IANI column used. For the ionized solutes, their retention is due to a balance of electrostatic and hydrophobie interactions. Thus no discrimination is observed between different series of solutes bearing the same charge, from one column to an other. Part III presents two examples illustrating the information obtained thanks to Structure-Properties Relationships (SPR). Comparing graphically lipophilicity values obtained in two different solvent systems allows to reveal the presence of intramolecular effects .such as internai H-bond (Chapter 6). SPR is used to study the partitioning of ionizable groups encountered in Medicinal Chemistry (Chapter7). Résumé La lipophilie joue un .rôle important dans la détermination et la compréhension du comportement pharmacocinétique des médicaments. Elle est généralement exprimée par le coefficient de partage (log P) d'un composé dans le système de solvants n-octanol/eau. L'utilisation d'un deuxième système de solvants (1,2-dichloroéthane/eau) s'est avérée nécessaire afin d'obtenir des informations complémentaires, les valeurs de log Poct seules n'étant pas suffisantes pour expliquer toutes les propriétés biologiques. Le but de cette thèse est de développer des outils permettant de prédire la lipophilie de nouveaux candidats médicaments et d'analyser l'information fournie par les valeurs de log P. La Partie I présente le développement de modèles théoriques utilisés pour prédire la lipophilie. Le chapitre 2 montre la nécessité de mettre à jour les analyses solvatochromiques existantes mais inadaptées à la prédiction de la lipophilie de nouveaux composés neutres. Dans le chapitre 3, la même méthodologie des analyses solvatochromiques est utilisée pour développer un modèle permettant de prédire la lipophilie des ions. Le modèle global obtenu permet la prédiction de la lipophilie de composés neutres, anioniques et cationiques. La Partie II présente l'étude approfondie de deux filtres physicochimiques. Le Chapitre 4 montre que la phase stationnaire Discovery RP Amide C16 permet la détermination de la lipophilie de la forme neutre de composés basiques et acides, à l'exception des acides très lipophiles. Ces derniers présentent des interactions supplémentaires avec cette phase stationnaire. Dans le Chapitre 5, 4 phases stationnaires IAM sont étudiées. Pour les composés neutres étudiés, des valeurs de rétention linéaires sont obtenues, quelque que soit la colonne IAM utilisée. Pour les composés ionisables, leur rétention est due à une balance entre des interactions électrostatiques et hydrophobes. Donc aucune discrimination n'est observée entre les différentes séries de composés portant la même charge d'une colonne à l'autre. La Partie III présente deux exemples illustrant les informations obtenues par l'utilisation des relations structures-propriétés. Comparer graphiquement la lipophilie mesurée dans deux différents systèmes de solvants permet de mettre en évidence la présence d'effets intramoléculaires tels que les liaisons hydrogène intramoléculaires (Chapitre 6). Cette approche des relations structures-propriétés est aussi appliquée à l'étude du partage de fonctions ionisables rencontrées en Chimie Thérapeutique (Chapitre 7) Résumé large public Pour exercer son effet thérapeutique, un médicament doit atteindre son site d'action en quantité suffisante. La quantité effective de médicament atteignant le site d'action dépend du nombre d'interactions entre le médicament et de nombreux constituants de l'organisme comme, par exemple, les enzymes du métabolisme ou les membranes biologiques. Le passage du médicament à travers ces membranes, appelé perméation, est un paramètre important à optimiser pour développer des médicaments plus puissants. La lipophilie joue un rôle clé dans la compréhension de la perméation passive des médicaments. La lipophilie est généralement exprimée par le coefficient de partage (log P) dans le système de solvants (non miscibles) n-octanol/eau. Les valeurs de log Poct seules se sont avérées insuffisantes pour expliquer la perméation à travers toutes les différentes membranes biologiques du corps humain. L'utilisation d'un système de solvants additionnel (le système 1,2-dichloroéthane/eau) a permis d'obtenir les informations complémentaires indispensables à une bonne compréhension du processus de perméation. Un grand nombre d'outils expérimentaux et théoriques sont à disposition pour étudier la lipophilie. Ce travail de thèse se focalise principalement sur le développement ou l'amélioration de certains de ces outils pour permettre leur application à un champ plus large de composés. Voici une brève description de deux de ces outils: 1)La factorisation de la lipophilie en fonction de certaines propriétés structurelles (telle que le volume) propres aux composés permet de développer des modèles théoriques utilisables pour la prédiction de la lipophilie de nouveaux composés ou médicaments. Cette approche est appliquée à l'analyse de la lipophilie de composés neutres ainsi qu'à la lipophilie de composés chargés. 2)La chromatographie liquide à haute pression sur phase inverse (RP-HPLC) est une méthode couramment utilisée pour la détermination expérimentale des valeurs de log Poct.

Prospective evaluation of three point of care devices for glycemia measurement in a neonatal intensive care unit.

Hypoglycemia, if recurrent, may have severe consequences on cognitive and psychomotor development of neonates. Therefore, screening for hypoglycemia is a daily routine in every facility taking care of newborn infants. Point-of-care-testing (POCT) devices are interesting for neonatal use, as their handling is easy, measurements can be performed at bedside, demanded blood volume is small and results are readily available. However, such whole blood measurements are challenged by a wide variation of hematocrit in neonates and a spectrum of normal glucose concentration at the lower end of the test range. We conducted a prospective trial to check precision and accuracy of the best suitable POCT device for neonatal use from three leading companies in Europe. Of the three devices tested (Precision Xceed, Abbott; Elite XL, Bayer; Aviva Nano, Roche), Aviva Nano exhibited the best precision. None completely fulfilled the ISO-accuracy-criteria 15197: 2003 or 2011. Aviva Nano fulfilled these criteria in 92% of cases while the others were <87%. Precision Xceed reached the 95% limit of the 2003 ISO-criteria for values ≤4.2 mmol/L, but not for the higher range (71%). Although validated for adults, new POCT devices need to be specifically evaluated on newborn infants before adopting their routine use in neonatology.

Comparación de tres métodos de medición de hemoglobina en cirugía cardiaca

Durante la cirugía cardiaca con circulación extracorpórea (CEC) el umbral transfusional hemático está basado en el valor de las cifras de hemoglobina y/o hematocrito. Estos valores se obtienen mediante las máquinas tipo “point-of-care testing” (POCT) que están presentes en quirófano y en las unidades de reanimación. En nuestro centro hay distintos tipos de máquinas POCT. Todas miden la cantidad de hemoglobina y/o el porcentaje de hematocrito pero cada una de ellas utiliza una metodología diferente para medir los parámetros sanguíneos: (i) la conductividad, y (ii) la espectrofotometría. En este trabajo comparamos cada uno de los POCT con respecto a la máquina de referencia durante la cirugía cardiaca con CEC, buscando (1) la posible existencia de errores sistemáticos en los POCT al medir las cifras de hemoglobina y hematocrito, y (2) la validez de cada POCT para detector el umbral de transfusión.

Evaluation of two HbA1c point-of-care analyzers.

BACKGROUND Measurement of HbA1c is the most important parameter to assess glycemic control in diabetic patients. Different point-of-care devices for HbA1c are available. The aim of this study was to evaluate two point-of-care testing (POCT) analyzers (DCA Vantage from Siemens and Afinion from Axis-Shield). We studied the bias and precision as well as interference from carbamylated hemoglobin. METHODS Bias of the POCT analyzers was obtained by measuring 53 blood samples from diabetic patients with a wide range of HbA1c, 4%-14% (20-130 mmol/mol), and comparing the results with those obtained by the laboratory method: HPLC HA 8160 Menarini. Precision was performed by 20 successive determinations of two samples with low 4.2% (22 mmol/mol) and high 9.5% (80 mmol/mol) HbA1c values. The possible interference from carbamylated hemoglobin was studied using 25 samples from patients with chronic renal failure. RESULTS The means of the differences between measurements performed by each POCT analyzer and the laboratory method (95% confidence interval) were: 0.28% (p<0.005) (0.10-0.44) for DCA and 0.27% (p<0.001) (0.19-0.35) for Afinion. Correlation coefficients were: r=0.973 for DCA, and r=0.991 for Afinion. The mean bias observed by using samples from chronic renal failure patients were 0.2 (range -0.4, 0.4) for DCA and 0.2 (-0.2, 0.5) for Afinion. Imprecision results were: CV=3.1% (high HbA1c) and 2.97% (low HbA1c) for DCA, CV=1.95% (high HbA1c) and 2.66% (low HbA1c) for Afinion. CONCLUSIONS Both POCT analyzers for HbA1c show good correlation with the laboratory method and acceptable precision.

Conworx POCceleratoretävalvontaohjelma vierianalytiikan kehittäjänä

Vierianalytiikan (POCT = point-of-care testing) käyttäjämäärien lisääntyminen, resurssien puute ja kiire osastoilla lisäävät virhemahdollisuuksia vierianalytiikassa. Saksalainen Conworx yhtiö on kehittänyt vierianalytiikan ongelmien ehkäisyyn POCcelerator etävalvontaohjelman. Ohjelmaan saadaan yhdistettyä useimmat käytössä olevat vierianalytiikkalaitteet ja sen avulla voidaan valvoa laitteita, käyttäjiä, tarvikkeiden kulutusta ja kontrolleja. Tässä työssä arvioitiin POCcelerator etävalvontaohjelman toimittajan lupaamien toimintojen toteutumista projektiin osallistuvilla laitteilla. Projektissa tarkasteltiin ohjelman toimittajan ilmoittamien osakokonaisuuksien toimivuutta kolmella eri laitetyypillä, jotka sijaitsivat neljällä eri osastolla. Projektissa olivat mukana Radiometerin ABL 725 ja ABL 825 verikaasuanalysaattorit sekä kuusi i-Stat laitetta, joista viidellä määritettiin verikaasuja ja yhdellä INR arvoja. Toimivuutta tarkasteltiin seuraamalla tietojen siirtymistä etäohjelmaan ja vertailemalla virheilmoituksia primäärilaitteen ja etäohjelman välillä. Etävalvontaohjelmaprojektin yhteydessä toteutettiin myös kysely projektiin osallistuvilla osastoilla. Kyselyn avulla pyrittiin arvioimaan POCcelerator etävalvontaohjelman sopivuutta ja vierianalytiikan käytänteitä projektiin osallistuvilla osastoilla. Kaikki potilastulokset siirtyivät hyvin POCcelerator etävalvontaohjelmaan kaikilta projektissa mukana olleilta laitteilta. Kontrollitulokset siirtyivät kontrollitiedostoon ABL analysaattoreilta, mutta i-Stat laitteilta siirtyi vain elektroninen kontrollitulos. Potilaan identifiointi ja käyttäjän kirjautuminen viivakoodilla siirtyi hyvin kaikilta laitteilta etävalvontaohjelmaan. Kyselytutkimuksesta saatujen tulosten mukaan vierianalytiikkalaitteiden käyttö on helppoa, mutta päivittäisiä huoltoja ei kovin hyvin hallita. Etävalvontaohjelmalla ei nähty olevan apua vierianalytiikka toimintaan osastoilla. Laboratoriosta halutaan apua tarvittaessa ja lisää koulutusta laitteiden käytöstä. POCcelerator etävalvontaohjelma sisältää HUSLABin edellyttämät etävalvontaohjelman vaatimukset, mutta laboratoriosta käsin ei ole mahdollista saada ABL analysaattoreita esim. pesemään tai ajamaan kontrollinäytettä (Remote control). Tämä ominaisuus koetaan välttämättömäksi etävalvontaohjelmalle.

Efeito de tratamento de superfície na resistência de união de uma liga de Cobalto - Cromo e uma resina acrílica termicamente ativada

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Development of muliplexed analytical methods based on bioluminescent whole-cell biosensors

The subject of this Ph.D. research thesis is the development and application of multiplexed analytical methods based on bioluminescent whole-cell biosensors. One of the main goals of analytical chemistry is multianalyte testing in which two or more analytes are measured simultaneously in a single assay. The advantages of multianalyte testing are work simplification, high throughput, and reduction in the overall cost per test. The availability of multiplexed portable analytical systems is of particular interest for on-field analysis of clinical, environmental or food samples as well as for the drug discovery process. To allow highly sensitive and selective analysis, these devices should combine biospecific molecular recognition with ultrasensitive detection systems. To address the current need for rapid, highly sensitive and inexpensive devices for obtaining more data from each sample,genetically engineered whole-cell biosensors as biospecific recognition element were combined with ultrasensitive bioluminescence detection techniques. Genetically engineered cell-based sensing systems were obtained by introducing into bacterial, yeast or mammalian cells a vector expressing a reporter protein whose expression is controlled by regulatory proteins and promoter sequences. The regulatory protein is able to recognize the presence of the analyte (e.g., compounds with hormone-like activity, heavy metals…) and to consequently activate the expression of the reporter protein that can be readily measured and directly related to the analyte bioavailable concentration in the sample. Bioluminescence represents the ideal detection principle for miniaturized analytical devices and multiplexed assays thanks to high detectability in small sample volumes allowing an accurate signal localization and quantification. In the first chapter of this dissertation is discussed the obtainment of improved bioluminescent proteins emitting at different wavelenghts, in term of increased thermostability, enhanced emission decay kinetic and spectral resolution. The second chapter is mainly focused on the use of these proteins in the development of whole-cell based assay with improved analytical performance. In particular since the main drawback of whole-cell biosensors is the high variability of their analyte specific response mainly caused by variations in cell viability due to aspecific effects of the sample’s matrix, an additional bioluminescent reporter has been introduced to correct the analytical response thus increasing the robustness of the bioassays. The feasibility of using a combination of two or more bioluminescent proteins for obtaining biosensors with internal signal correction or for the simultaneous detection of multiple analytes has been demonstrated by developing a dual reporter yeast based biosensor for androgenic activity measurement and a triple reporter mammalian cell-based biosensor for the simultaneous monitoring of two CYP450 enzymes activation, involved in cholesterol degradation, with the use of two spectrally resolved intracellular luciferases and a secreted luciferase as a control for cells viability. In the third chapter is presented the development of a portable multianalyte detection system. In order to develop a portable system that can be used also outside the laboratory environment even by non skilled personnel, cells have been immobilized into a new biocompatible and transparent polymeric matrix within a modified clear bottom black 384 -well microtiter plate to obtain a bioluminescent cell array. The cell array was placed in contact with a portable charge-coupled device (CCD) light sensor able to localize and quantify the luminescent signal produced by different bioluminescent whole-cell biosensors. This multiplexed biosensing platform containing whole-cell biosensors was successfully used to measure the overall toxicity of a given sample as well as to obtain dose response curves for heavy metals and to detect hormonal activity in clinical samples (PCT/IB2010/050625: “Portable device based on immobilized cells for the detection of analytes.” Michelini E, Roda A, Dolci LS, Mezzanotte L, Cevenini L , 2010). At the end of the dissertation some future development steps are also discussed in order to develop a point of care (POCT) device that combine portability, minimum sample pre-treatment and highly sensitive multiplexed assays in a short assay time. In this POCT perspective, field-flow fractionation (FFF) techniques, in particular gravitational variant (GrFFF) that exploit the earth gravitational field to structure the separation, have been investigated for cells fractionation, characterization and isolation. Thanks to the simplicity of its equipment, amenable to miniaturization, the GrFFF techniques appears to be particularly suited for its implementation in POCT devices and may be used as pre-analytical integrated module to be applied directly to drive target analytes of raw samples to the modules where biospecifc recognition reactions based on ultrasensitive bioluminescence detection occurs, providing an increase in overall analytical output.

Development and characterization of micromachined devices for separation techniques

Nowadays microfluidic is becoming an important technology in many chemical and biological processes and analysis applications. The potential to replace large-scale conventional laboratory instrumentation with miniaturized and self-contained systems, (called lab-on-a-chip (LOC) or point-of-care-testing (POCT)), offers a variety of advantages such as low reagent consumption, faster analysis speeds, and the capability of operating in a massively parallel scale in order to achieve high-throughput. Micro-electro-mechanical-systems (MEMS) technologies enable both the fabrication of miniaturized system and the possibility of developing compact and portable systems. The work described in this dissertation is towards the development of micromachined separation devices for both high-speed gas chromatography (HSGC) and gravitational field-flow fractionation (GrFFF) using MEMS technologies. Concerning the HSGC, a complete platform of three MEMS-based GC core components (injector, separation column and detector) is designed, fabricated and characterized. The microinjector consists of a set of pneumatically driven microvalves, based on a polymeric actuating membrane. Experimental results demonstrate that the microinjector is able to guarantee low dead volumes, fast actuation time, a wide operating temperature range and high chemical inertness. The microcolumn consists of an all-silicon microcolumn having a nearly circular cross-section channel. The extensive characterization has produced separation performances very close to the theoretical ideal expectations. A thermal conductivity detector (TCD) is chosen as most proper detector to be miniaturized since the volume reduction of the detector chamber results in increased mass and reduced dead volumes. The microTDC shows a good sensitivity and a very wide dynamic range. Finally a feasibility study for miniaturizing a channel suited for GrFFF is performed. The proposed GrFFF microchannel is at early stage of development, but represents a first step for the realization of a highly portable and potentially low-cost POCT device for biomedical applications.

La diagnostica molecolare nel laboratorio di patologia clinica veterinaria

La prima parte del nostro studio riguarda la tecnica LAMP (Loop-mediated isothermal amplification), una tecnica di amplificazione isotermica recentemente inventata (Notomi et al., 2000). Essa presenta notevoli vantaggi rispetto alle tradizionali PCR: non necessita di strumentazioni sofisticate come i termociclatori, può essere eseguita da personale non specializzato, è una tecnica altamente sensibile e specifica ed è molto tollerante agli inibitori. Tutte queste caratteristiche fanno sì che essa possa essere utilizzata al di fuori dei laboratori diagnostici, come POCT (Point of care testing), con il vantaggio di non dover gestire la spedizione del campione e di avere in tempi molto brevi risultati paragonabili a quelli ottenuti con la tradizionale PCR. Sono state prese in considerazione malattie infettive sostenute da batteri che richiedono tempi molto lunghi per la coltivazione o che non sono addirittura coltivabili. Sono stati disegnati dei saggi per la diagnosi di patologie virali che necessitano di diagnosi tempestiva. Altri test messi a punto riguardano malattie genetiche del cane e due batteri d’interesse agro-alimentare. Tutte le prove sono state condotte con tecnica real-time per diminuire il rischio di cross-contaminazione pur riuscendo a comprendere in maniera approfondita l’andamento delle reazioni. Infine è stato messo a punto un metodo di visualizzazione colorimetrico utilizzabile con tutti i saggi messi a punto, che svincola completamente la reazione LAMP dall’esecuzione in un laboratorio specializzato. Il secondo capitolo riguarda lo studio dal punto di vista molecolare di un soggetto che presenza totale assenza di attività mieloperossidasica all’analisi di citochimica automatica (ADVIA® 2120 Hematology System). Lo studio è stato condotto attraverso amplificazione e confronto dei prodotti di PCR ottenuti sul soggetto patologico e su due soggetti con fenotipo wild-type. Si è poi provveduto al sequenziamento dei prodotti di PCR su sequenziatore automatico al fine di ricercare la mutazione responsabile della carenza di MPO nel soggetto indicato.